Beijing Anding Hospital

Futó vizsgálatok

• Még nem toboroz

  Context-Guided Personalized iTBS for Depression

  NCT07743398· Capital Medical University· Forrás

• Toboroz

  A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

  NCT07775300· 3. fázis· Eli Lilly and Company· Forrás

• Még nem toboroz

  A Phase 2 Study to Evaluate the Efficacy and Safety of LY03020 in Acutely Psychotic Participants With Schizophrenia

  NCT07396870· 2. fázis· Luye Pharma Group Ltd.· Forrás

• Toboroz

  A Study of Brenipatide in Adult Participants With Major Depressive Disorder

  NCT07412756· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

  NCT07140913· 3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020

  NCT07230652· 1. fázis· Luye Pharma Group Ltd.· Forrás

• Fut, nem toboroz

  A Food Effect Study of LY03020 in Healthy Subjects

  NCT07292233· 1. fázis· Luye Pharma Group Ltd.· Forrás

• Toboroz

  A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

  NCT07011732· 3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

  NCT06951711· 3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  Assessment of the Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients With Major Depressive Disorder

  NCT06692361· Gang Wang· Forrás

• Fut, nem toboroz

  A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)

  NCT06653153· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Bioequivalence Study of PP3M in Patients With Schizophrenia

  NCT07493551· CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.· Forrás

• Toboroz

  A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

  NCT06585787· 3. fázis· Karuna Therapeutics, Inc., a Bristol Myers Squibb company· Forrás

• Még nem toboroz

  Implementation Research on the Intervention Mode of " Comorbidity-Co-causes-Joint-prevention" Comprehensive Demonstration District of Depression and Obesity Among Children and Adolescents in Beijing

  NCT06489990· Capital Medical University· Forrás

• Toboroz

  The Purpose of This Study is to Determine the Safety, Tolerability, and Pharmacokinetics of Brexpiprazole Long-acting Injection Following a Single Administration in Healthy Subjects/Patients With Schizophrenia.

  NCT06674694· 1. fázis· Sichuan Kelun Pharmaceutical Co.,Ltd.· Forrás

• Toboroz

  App and Body Fat Scale in the Management of Overweight Patients

  NCT05866107· Capital Medical University· Forrás

• Toboroz

  An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease

  NCT05908695· 4. fázis· Green Valley (Shanghai) Pharmaceuticals Co., Ltd.· Forrás

• Toboroz

  Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

  NCT05980949· 3. fázis· Karuna Therapeutics, Inc., a Bristol Myers Squibb company· Forrás

• Fut, nem toboroz

  Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD)

  NCT05531526· 3. fázis· AriBio Co., Ltd.· Forrás

• Fut, nem toboroz

  A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)

  NCT05508789· 3. fázis· Eli Lilly and Company· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Skizofrénia6 toboroz
• Alzheimer-kór5 toboroz
• Depresszió4 toboroz
• Bipoláris zavar3 toboroz
• Elhízás2 toboroz

Lezárt vizsgálatok

• Lezárult

  Stereotactic Radiotherapy Treatment for Treatment-Resistant Depression

  NCT07274917· Capital Medical University· Forrás

• Lezárult

  A Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Characteristics of (R)-Ketamine Hydrochloride Nasal Spray in Patients With Depression and Acute Suicidal Ideation or Behavior

  NCT07193901· 2. fázis· Sichuan Purity Pharmaceutical Technology Co., Ltd.· Forrás

• Lezárult

  A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Adult Participents With Major Depressive Disorder

  NCT07101120· 2. fázis· Chengdu Kanghong Pharmaceutical Group Co., Ltd.· Forrás

• Lezárult

  Efficacy and Safety Study of Levomilnacipran Hydrochloride Extended-Release Capsules in Major Depressive Disorder

  NCT07253207· 3. fázis· Zhejiang Huahai Pharmaceutical Co., Ltd.· Forrás

• Lezárult

  A Study Assessing the Safety and Tolerability of LY03020 in Chinese Healthy Subjects

  NCT06556966· 1. fázis· Luye Pharma Group Ltd.· Forrás

• Lezárult

  Bioequivalence Study of Long-Acting Paliperidone Palmitate in Patients With Schizophrenia

  NCT07268430· CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.· Forrás

• Lezárult

  A Study to Assess the Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Chinese Adult Subjects With DSM-5 Schizophrenia

  NCT05919823· 3. fázis· Karuna Therapeutics, Inc., a Bristol Myers Squibb company· Forrás

• Lezárult

  Study of 50561 in Patients With Mild or Moderate Alzheimer's Disease

  NCT05811442· 2. fázis· Beijing Joekai Biotechnology LLC· Forrás

• Lezárult

  CONNEX-3: A Study to Test Whether Iclepertin Improves Learning and Memory in People With Schizophrenia

  NCT04860830· 3. fázis· Boehringer Ingelheim· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Depresszió73 munka · 8 vizsgálat
• Skizofrénia33 munka · 11 vizsgálat
• Insomnia17 munka · 0 vizsgálat